🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pharmacogenetics is an area of Pharmacology that studies the contribution o...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT02450487
Treatments Being Tested
Microbiota contributes to the immunological, hormonal and metabolic homeost...
Status
Unknown
Location
Koc University Hospital
Start Date
2020-04-01
Trial ID
NCT04165252
Treatments Being Tested
This case-control study will be conducted between January and June 2026 and...
Status
Enrolling By Invitation
Location
University of babylon
Start Date
2026-01-31
Trial ID
NCT07579338
This prospective cohort study is part of the Clinnova programme and aims to...
Status
Recruiting
Location
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Start Date
2024-12-10
Trial ID
NCT06526364
Treatments Being Tested
Nephrotic syndrome (NS) is a clinical picture common to several diseases re...
Status
Unknown
Location
Meyer Children's Hospital IRCCS
Start Date
2022-01-26
Trial ID
NCT06325098
Treatments Being Tested
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
This study is a prospective study aimed to validate the performance of comb...
Status
Unknown
Location
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Start Date
2023-02-22
Trial ID
NCT06001099
Currently, one of the main health challenges of public health is to improve...
Status
Completed
Location
Basque Culinary Center Fundazioa
Start Date
2021-05-26
Trial ID
NCT04908163
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested